{"id":"W2133353215","doi":"10.1517/14656566.7.2.177","title":"A review of erlotinib and its clinical use","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Erlotinib; Medicine; Rash; Epidermal growth factor receptor; Gemcitabine; Clinical trial; Oncology; Erlotinib Hydrochloride; Internal medicine; Gefitinib; Lung cancer; Tyrosine-kinase inhibitor; Pancreatic cancer; Pharmacology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006754687,0.001019822,0.001849138,0.00280859,0.0003494716,0.001183522,0.00119711,0.001368111,0.006112926],"category_scores_gemma":[0.000958127,0.0003694624,0.0005500176,0.003372858,0.0003744647,0.001576849,0.000551292,0.001534284,0.00442813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008241389,"about_ca_system_score_gemma":0.001083737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001069143,"about_ca_topic_score_gemma":0.002509151,"domain_scores_codex":[0.9996756,0.00006802906,0.00006003973,0.00004915835,0.0001281378,0.00001905216],"domain_scores_gemma":[0.9996973,0.0001228242,0.00005864442,0.000008426627,0.00007648099,0.00003635247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001130196,0.0001000648,0.0001023133,0.01824935,0.00008285657,0.0004427726,0.00005744119,0.0003043674,0.001002427,0.00133896,0.07084186,0.9073645],"study_design_scores_gemma":[0.00003177942,0.0001093311,0.000582882,0.004681282,0.00008567092,0.001962562,0.00004479583,0.00006485989,0.0002086417,0.0007144887,0.9914989,0.00001488621],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008913797,0.9981705,0.00007661803,0.0002828221,0.0002978478,0.000006240665,0.00001738461,0.000006250451,0.001053336],"genre_scores_gemma":[0.0003741683,0.9980764,0.0001690177,0.0002788742,0.0003359884,0.000009314798,0.00002967526,0.000001375942,0.0007251772],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006112926,"threshold_uncertainty_score":0.02044982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2225099471447932,"score_gpt":0.5773877545529791,"score_spread":0.3548778074081859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}